The Incubator

SAB Biotherapeutics: Therapeutic neutralized COVID-19

Sioux Falls-based SAB Biotherapeutics has confirmed that its treatment in development specifically for the virus that causes COVID-19 has produced antibodies that neutralized the virus in a way that’s four times as potent as using plasma from recovered patients.

4 days ago

Falcon Plastics mass produces ear guards for health care workers  

A Scout’s design, a request from a friend and some South Dakota ingenuity have led to a more comfortable day for nearly 100,000 health care workers.

2 weeks ago

CNN features SAB Biotherapeutics

The COVID-19 therapeutic being developed by Sioux Falls-based SAB Biotherapeutics has been featured in a CNN report.

2 weeks ago

Sanford to participate in COVID-19 stem cell clinical trial

 Sanford Health is one of two places in the country that will begin treating some COVID-19 patients with umbilical cord stem cells as part of a first-of-its-kind clinical trial. 

3 weeks ago

Sioux Falls stock market site charts strong growth despite volatile market

Regardless of the market, we think you’ll agree this Sioux Falls company’s stock is up. With a new office and a big ranking, MarketBeat keeps growing.

1 month ago

Dakota State University, Madison Regional Health System, Global Polymer soar into action to protect area health workers

DSU has mobilized to partner with an area hospital and business to start producing needed personal protective equipment for health care workers.

2 months ago

Global animal feed company expands to Canton location

“We have been a little ahead of our time in the animal feed industry.” This innovative company now has a new home in Canton.

2 months ago

SAB joins forces with Pennsylvania company to develop COVID-19 therapeutic

Sioux Falls-based SAB Biotherapeutics is joining with global biotherapeutics leader CSL Behring to rapidly develop SAB-185, a COVID-19 therapeutic candidate on track for clinical evaluation by early summer.

2 months ago

SAB Biotherapeutics awarded up to $27 million to test rapid response antibodies

Sioux Falls-based SAB Biotherapeutics will receive up to $27 million from the U.S. Department of Defense to develop and test a rapid response antibody program .

2 months ago

Biotech industry: We’re coming together to fight COVID-19

We think you’ll be encouraged by how the nation’s biotech companies — including a big player in Sioux Falls — are banding together to fight COVID-19.

2 months ago

News Tip

Have a business news item to share with us?

Scroll to top